A Proud Moment for the Team

We’re excited to share that THERANOVIR was selected to pitch at the New England Venture Summit 2025 (hashtag#NEVS25), organised by youngStartup Ventures, one of the premier startup events bringing together top-tier early-stage companies, venture capitalists, corporate investors, and strategic partners from across the ecosystem. 

Our CEO, Zakia BELAID-SANDAL, was on the ground at the Hilton Boston/Dedham on December 9–10, where she had the opportunity to present Theranovir’s vision and breakthrough work in Health-Tech; from innovative oncology and metabolic disease research to novel therapeutic approaches addressing obesity. 

It was an invaluable experience to:

 - Pitch to an audience of leading investors and industry experts

 - Connect with founders, VCs, and potential collaborators

 - Gain insights into emerging trends and opportunities in biotech and deep tech

Thank you to the youngStartup Ventures team and all the organisers for hosting such a dynamic and inspiring summit. 

We look forward to building on the momentum and advancing Theranovir’s mission with continued support and engagement!

hashtag#startup hashtag#biotech hashtag#healthtech hashtag#innovation hashtag#venturecapital hashtag#entrepreneurship hashtag#NEVS25